BMO Capital Markets Issues Positive Forecast for Kinaxis (TSE:KXS) Stock Price

Kinaxis (TSE:KXSGet Free Report) had its price target boosted by equities researchers at BMO Capital Markets from C$195.00 to C$200.00 in a research report issued to clients and investors on Friday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. BMO Capital Markets’ target price would suggest a potential upside of 14.84% from the company’s previous close.

Several other brokerages have also recently commented on KXS. Canadian Imperial Bank of Commerce lifted their price objective on shares of Kinaxis from C$173.00 to C$205.00 in a research note on Friday, June 5th. Royal Bank Of Canada increased their price objective on shares of Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a research note on Friday, May 8th. Stifel Nicolaus decreased their target price on shares of Kinaxis from C$245.00 to C$200.00 and set a “buy” rating for the company in a research report on Wednesday, May 6th. Finally, National Bank Financial upped their price target on shares of Kinaxis from C$200.00 to C$210.00 and gave the company an “outperform” rating in a report on Friday. Seven investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average price target of C$203.12.

Get Our Latest Analysis on Kinaxis

Kinaxis Stock Performance

Shares of KXS stock traded up C$4.19 during mid-day trading on Friday, reaching C$174.15. The stock had a trading volume of 85,293 shares, compared to its average volume of 122,823. Kinaxis has a 1-year low of C$117.22 and a 1-year high of C$204.85. The firm has a market cap of C$4.76 billion, a price-to-earnings ratio of 59.23, a PEG ratio of 3.60 and a beta of 0.76. The company has a current ratio of 1.72, a quick ratio of 2.29 and a debt-to-equity ratio of 12.15. The business’s fifty day moving average is C$157.76 and its 200-day moving average is C$144.97.

Kinaxis (TSE:KXSGet Free Report) last released its earnings results on Wednesday, August 5th. The company reported C$1.08 EPS for the quarter. The firm had revenue of C$230.64 million during the quarter. Kinaxis had a return on equity of 19.72% and a net margin of 14.48%. On average, research analysts forecast that Kinaxis will post 4.2526231 earnings per share for the current year.

Insider Activity at Kinaxis

In related news, Director Robert G. Courteau sold 5,010 shares of the business’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of C$151.39, for a total value of C$758,463.90. Following the completion of the transaction, the director directly owned 32,945 shares in the company, valued at C$4,987,543.55. The trade was a 13.20% decrease in their position. Also, insider Conrad John Mandala sold 924 shares of the stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of C$137.14, for a total transaction of C$126,717.36. Following the sale, the insider directly owned 820 shares in the company, valued at C$112,454.80. This trade represents a 52.98% decrease in their ownership of the stock. In the last 90 days, insiders sold 35,934 shares of company stock worth $5,328,181. Insiders own 1.20% of the company’s stock.

Kinaxis Company Profile

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.